Recombinant Phytolacca dioica

Bispecific Monoclonal Antibodies for the Targeting of Type I Ribosome-Inactivating Proteins Against Hematological Malignancies

for the generation of ITs, although several other single-chain ribosome-inactivating proteins (RIPs) or type I RIPs are also available (3 ). Type I RIPs are RNA N -glycosidases displaying potent inhibition of protein synthesis in cell-free assays, but they lack

Ribosome Display and Screening for Protein Therapeutics

Ribosome display is a cell-free display technology which enables in vitro selection of antibodies from large recombinant DNA libraries. It also allows continuous introduction of mutations into the selected DNA pool by PCR-based mutagenesis

Overview of Protein Microarrays

for influenza virus replication. Nature 463:818‐822.    Knappik, A. and Brundiers, R., 2009. Recombinant antibody expression and purification. In The Protein Protocols Handbook, 3rd ed